|
|
Other links at Articles > Business of Medicine |
| 2. |
Biotech Cash Crunch Threatens New Medicines: UK Expert
|
|
|
The global credit crunch, which has already pushed some small biotechnology companies to the wall, could seriously delay the discovery of new life-saving medicines, a British expert warned on Monday. Reuters Health Information
|
| 3. |
FDA Approvals: Pristiq and Abilify
|
|
|
The FDA has approved desvenlafaxine extended-release tablets (Pristiq) and a supplemental indication for oral and injectable aripiprazole (Abilify). Medscape Medical News
|
| 4. |
WellPoint Profit Slumps, but Shares Rally
|
|
|
WellPoint Inc reported a 25 percent decline in quarterly profit on Wednesday and cut its full-year forecast, but its shares rallied on hopes the health insurer can contain problems that have plagued it. Reuters Health Information
|
| 5. |
U.S. Senate Revises Drugmaker Gift Bill
|
|
|
A revised U.S. Senate bill would require drugmakers and medical device makers to publicly report gifts over $500 a year to doctors, watering down the standard set in a previous version. Reuters Health Information
|
|
|
